Nevro Corp. (NVRO)
NYSE: NVRO · Real-Time Price · USD
5.03
-0.10 (-1.95%)
Feb 5, 2025, 3:38 PM EST - Market open
Nevro Market Cap
Nevro has a market cap or net worth of $188.48 million as of February 5, 2025. Its market cap has decreased by -72.03% in one year.
Market Cap
188.48M
Enterprise Value
159.13M
1-Year Change
-72.03%
Ranking
Category
Stock Price
$5.03
Market Cap Chart
Since November 6, 2014, Nevro's market cap has decreased from $574.20M to $188.48M, a decrease of -67.17%. That is a compound annual growth rate of -10.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2025 | 192.20M | 37.88% |
| Dec 31, 2024 | 139.40M | -82.11% |
| Dec 29, 2023 | 779.10M | -44.47% |
| Dec 30, 2022 | 1.40B | -50.42% |
| Dec 31, 2021 | 2.83B | -52.52% |
| Dec 31, 2020 | 5.96B | 63.52% |
| Dec 31, 2019 | 3.64B | 210.75% |
| Dec 31, 2018 | 1.17B | -42.66% |
| Dec 29, 2017 | 2.05B | -2.13% |
| Dec 30, 2016 | 2.09B | 10.82% |
| Dec 31, 2015 | 1.89B | 96.32% |
| Dec 31, 2014 | 960.70M | 67.31% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.74B |
| UnitedHealth Group | 504.48B |
| Novo Nordisk | 367.70B |
| Johnson & Johnson | 365.65B |
| AbbVie | 336.00B |
| Merck & Co. | 252.43B |
| Thermo Fisher Scientific | 227.11B |
| Abbott Laboratories | 222.79B |